Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-03-11
1999-08-10
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549417, 549420, A01N 4316, C07D31500
Patent
active
059359951
ABSTRACT:
Compounds of the formula I compound (I)
are described which are suitable for the treatment of carcinomatous diseases, autoimmune diseases and chronic inflammatory diseases such as rheumatoid arthritis.
REFERENCES:
patent: 5284856 (1994-02-01), Naik et al.
patent: 5532259 (1996-07-01), Bartlett et al.
patent: 5561119 (1996-10-01), Jacquesy et al.
Sharma et al., "Antibody Directed Enzyme Prodrug Therapy (ADEPT): A Three Phase System," Disease Markers, vol. 9, pp. 225-231, 1991.
Bosslet et al., "A novel one-step tumor-selective prodrug activation system," Tumor Targeting, vol. 1, pp. 45-50, 1995.
Blakey et al., "Anti-tumour effects of an antibody--carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs," British Journal of Cancer, vol. 72, pp. 1083-1088, 1995.
Bosslet et al., "Tumor-selective Prodrug Activation by Fusion Protein-mediated Catalysis," Cancer Research, vol. 54, No. 8, pp. 2151-2159, 1994.
Trinh et al., "Enzyme/Prodrug Gene Therapy: Comparison of Cytosine Deaminase/5-Fluorocytosine Versus Thymidine Kinase/Ganciclovir Enzyme/Prodrug Systems in a Human Colorectal Carcinoma Cell Line," Cancer Research, vol. 55. pp. 4408-4812, 1995.
Bagshawe, "Antibody directed anzymes revive anti-cancer prodrugs concept," Br. J. Cancer, vol. 56, pp. 531-532, 1987.
Wang et al., "Activation of Glucuronide Prodrugs by Ligand-.beta.-glucuronidase Conjugates for Chemotherapy," Chem. Abst. No. 117782q, vol. 121, p. 625, (1994).
Bosslet Klaus
Czech Jorg
Florent Jean-Claude
Gerken Manfred
Monneret Claude
Heochst Aktiengesellschaft
Shah Mukund J.
Truong Tamthom N.
LandOfFree
Prodrugs for the therapy of tumors and inflammatory disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prodrugs for the therapy of tumors and inflammatory disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrugs for the therapy of tumors and inflammatory disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1120649